Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function

Peptides

Volumn 17, Issue 8, 1996, Pages 1365-1371

  Wright, John W ^a   Bechtholt, Anita J ^a   Chambers, Shelley L ^a   Harding, Joseph W ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Angiotensin analogues; Angiotensin II; Angiotensin III; Angiotensin IV; Blood pressure regulation; Divalinal; DuP753; Intracerebroventricular infusion; Rats; Receptor subtypes

Indexed keywords

ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN RECEPTOR; DIVALNAL; LOSARTAN; LOSARTAN POTASSIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CARDIOVASCULAR FUNCTION; DRUG STRUCTURE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANGIOTENSIN II; ANGIOTENSIN III; ANGIOTENSINS; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; HEART RATE; LIGANDS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN;

EID: 0030445262     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(96)00226-4     Document Type: Article

References (46)

1. 1. Bickerton, R. K.; Buckley, J. P. Evidence for a central mechanism of angiotensin induced hypertension. Proc. Soc. Exp. Biol. Med. 106:834-837; 1961.
2. 2. Braszko, J. J.; Kupryszewski, G.; Witczuk, B.; Wisniewski, K. Angiotensin II (3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats. Neuroscience 27:777-783; 1988.
3. 3. Braszko, J. J.; Wlasienko, J.; Koziolkiewicz, W.; Janecka, A.; Wisniewski, K. The 3-7 fragment of angiotensin II is probably responsible for its psychoactive properties. Brain Res. 542:49-54; 1991.
4. 4. Bredl, C. R.; Moe, K. E. The ability of angiotensin II vs. angiotensin III to arouse a salt appetite. Soc. Neurosci. Abstr. 13:1170; 1987.
5. 5. Buckley, J. P.; Jandhyala, B. S. Central cardiovascular effects of angiotensin. Life Sci. 20:1485-1494; 1977.
6. 6. Chauvel, E. N.; Coric, P.; Llorens-Cortes, C.; Wilk, S.; Roques, B. P.; Fourni'e-Zaluski, M. C. Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors. J. Med. Chem. 37:1139-1346; 1994.
7. 7. Chauvel, E. N.; Llorens-Cortes, C.; Coric, P.; Wilk, S.; Roques, B. P.; Fourai'e-Zaluski, M. C. Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols. J. Med. Chem. 37:2950-2957; 1994.
8. 8. Coleman, J. K.; Ong, B.; Sardinia, M.; Harding, J. W.; Wright, J. W. Changes in renal blood flow due to infusions of angiotensin II (3-8) [AIV] in normotensive rats. FASEB 6:A981; 1992.
9. 9. Epstein, A. M.; Fitsimons, J. T.; Rolls, B. J. Drinking induced by injection of angiotensin into the brain of the rat. J. Physiol. (Lond.) 210:457-474; 1970.
10. 10. Evered, M. D. Investigating the role of angiotensin II in thirst: Interactions between arterial pressure and the control of drinking. Can. J. Physiol. Pharmacol. 70:791-797; 1992.
11. 11. Felix, D.; Akert, K. The effect of angiotensin II on neurons of the cat subfornical organ. Brain Res. 76:350-353; 1974.
12. 12. Felix, D.; Imboden, H.; Schelling, P.; Harding, J. W. Electrophysiological assessment of central angiotensin function. In: Harding, J. W.; Wright, J. W.; Speth, R. C.; Barnes, C. D., Eds. Angiotensin and blood pressure regulation. San Diego, CA: Academic Press; 1988:165-208.
13. 13. Fink, G. D.; Bruner, C. A. Hypertension during chronic peripheral and central infusion of angiotensin III. Am. J. Physiol. 249:E201-E208; 1985.
14. 14. Fitzsimons, J. T. The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon. J. Physiol. (Lond.) 214:295-303; 1971.
15. 15. Haberl, R. L.; Decker, P. J.; Einhaupl, K. M. Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. Circ. Res. 68:1621-1627; 1991.
16. 16. Harding, J. W.; Cook, V. I.; Miller-Wing, A. V.; Hanesworth, J. M.; Sardinia, M. F.; Hall, K. L.; Stobb, J. W.; Swanson, G. N.; Coleman, J. K.; Wright, J. W.; Harding, E. C. Identification of an AII (3-8) [AIV] binding site in guinea pig hippocampus. Brain Res. 583:340-343; 1992.
17. 17. Harding, J. W.; Imboden, H.; Felix, D. Is angiotensin III the centrally active form of angiotensin? Experientia 42:706; 1986.
18. 125]angiotensins in rat. J. Neurochem. 46:1291-1297; 1986.
19. 19. Hoffman, W. E.; Phillips, M. I. Regional study of cerebral ventricular sensitive sites to angiotensin II. Brain Res. 110:313-330; 1976.
20. 20. Janiak, P.; Pillon, A.; Prost, J. F.; Vilaine, J. P. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 20:737-745; 1992.
21. 21. Moe, K. E.; Weiss, M. L.; Epstein, A. N. Sodium appetite during captopril blockade of endogenous angiotensin II formation. Am. J. Physiol. 247:R356-R365; 1984.
22. 22. Moore, G. J. Designing peptide mimetics. Trends Pharmacol. Sci. 15:124-129; 1994.
23. 23. Munoz-Ramirez, H.; Khosla, M. C.; Hall, M. M.; Bumpus, F. M.; Khairallah, P. A. In vitro and in vivo studies of [1-sarcosine, 8-threonine] angiotensin II. Res. Commun. Chem. Pathol. Pharmacol. 13P:649-663; 1976.
24. 2 receptor stimulation increases cerebrovascular resistance during hemorrhagic hypotension in rats. Regul. Pept. 52:21-29; 1994.
25. 25. Roberts, K. A.; Krebs, L. T.; Kramar, E. A.; Shaffer, M. J.; Harding, J. W.; Wright, J. W. Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats. Brain Res. 682:13-21; 1995.
26. 2 receptor antagonism and water intake. Brain Res. Bull. 32:391-394; 1993.
27. 27. Saavedra, J. M. Brain and pituitary angiotensin. Endocr. Rev. 13:329-380; 1992.
28. 4 receptor binding characteristics: D-amino acid-and glycine-substituted peptides. Peptides 14:949-954; 1993.
29. 29. Sasaki, S.; Li, Y. W.; Damphey, R. A. Comparison of the pressor effects of angiotensin II and III in the rostral ventrolateral medulla. Brain Res. 600:335-338; 1993.
30. 30. Speth, R. C.; Thompson, S. M.; Johns, S. J. Angiotensin II receptors: Structural and functional considerations. In: Mukhopadhyay, A. K.; Raizada, M. K., Eds. Current concepts: Tissue renin angiotensin systems as local regulators in reproductive and endocrine organs. New York: Plenum Press; 1995:169-192.
31. 2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats. J. Cereb. Blood Flow Metab. 13:298-303; 1993.
32. 32. Swanson, G. M.; Hanesworth, J. M.; Sardinia, M. F.; Coleman, J. K.; Wright, J. W.; Hall, K. L.; Miller-Wing, A. W.; Stobb, J. W.; Cook, V. I.; Harding, E. C.; Harding, J. W. Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin for a receptor. Regul. Pept. 40:409-419; 1992.
33. 33. Timmermans, E. B.; Wong, P. C.; Chiu, A. T.; Herblin, W. F.; Benfield, P.; Carini, D. J.; Lee, R. J.; Wexler, R. R.; Saye, J. A.; Smith, R. D. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45:205-251; 1993.
34. 34. Tonnaer, J. W.; Wiegant, V. M.; DeJong, W.; DeWied, D. Central effects of angiotensins on drinking and blood pressure: Structure-activity relationships. Brain Res. 236:417-428; 1982.
35. 35. Tseng, C. J.; Chou, L. L.; Ger, L. P.; Tung, C. S. Cardiovascular effects of angiotensin III in brainstem nuclei of normotensive and hypertensive rats. J. Pharmacol. Exp. Ther. 268:558-564; 1994.
36. 36. Wright, J. W.; Harding, J. W. A reevaluation of angiotensin III's potency as a presser and dipsogenic agent in normotensive and hypertensive animal models. In: Harding, J. W.; Wright, J. W.; Speth, R. C.; Barnes, C. D., Eds. Angiotensin and blood pressure regulation. San Diego: Academic Press; 1988:209-238.
37. 37. Wright, J. W.; Harding, J. W. Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res. Rev. 17:227-262; 1992.
38. 38. Wright, J. W.; Harding, J. W. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci. Biobehav. Rev. 18:21-53; 1994.
39. 4 and their functions. Regul. Pept. 59:269-295; 1995.
40. 40. Wright, J. W.; Amir, H. Z.; Murray, C. E.; Roberts, K. A.; Harding, J. W.; Mizutani, S.; Ward, P. E. Use of aminopeptidase M as a hypotensive agent in spontaneously hypertensive rats. Brain Res. Bull. 27:545-551; 1991.
41. 41. Wright, J. W.; Jensen, L. L.; Roberts, K. A.; Sardinia, M. F.; Harding, J. W. Structure-function analyses of brain angiotensin control of pressor action in rats. Am. J. Physiol. 257:R1551-R1557; 1989.
42. 42. Wright, J. W.; Krebs, L. T.; Stobb, J. W.; Harding, J. W. The angiotensin IV system: Functional implications. Front. Neuroendocrinol. 16:23-52; 1995.
43. 43. Wright, J. W.; Morseth, S. L.; Abhold, R. H.; Harding, J. W. Pressor action and dipsogenicity induced by angiotensin II and III in rats. Am. J. Physiol. 249:R514-R521; 1985.
44. 44. Wright, J. W.; Morseth, S. L.; Mana, M. J.; LaCross, E.; Petersen, E. P.; Harding, J. W. Central angiotensin III induced dipsogenicity in rats and gerbils. Brain Res. 295:121-126; 1984.
45. 1] angiotensin II, as a pressor agent in rats. Brain Res. 514:5-10; 1990.
46. 46. Wright, J. W.; Roberts, K. A.; Harding, J. W. Drinking to intracerebroventricularly infused angiotensin II, III, and IV in the SHR. Peptides 9:979-984; 1988.